Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-072918
Filing Date
2020-06-12
Accepted
2020-06-12 16:16:46
Documents
5
Effectiveness Date
2020-06-12

Document Format Files

Seq Description Document Type Size
1 S-8 tm2022347d1_s8.htm S-8 105718
2 EXHIBIT 5.1 tm2022347d1_ex5-1.htm EX-5.1 8993
3 EXHIBIT 23.1 tm2022347d1_ex23-1.htm EX-23.1 2333
4 EXHIBIT 99.1 tm2022347d1_ex99-1.htm EX-99.1 243285
5 GRAPHIC image_001.jpg GRAPHIC 2561
  Complete submission text file 0001104659-20-072918.txt   365286
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239136 | Film No.: 20960386
SIC: 2834 Pharmaceutical Preparations